Get the Stockscreener App
0.231
2.85%
0.0064
Pre-market:
.22
-0.011
-4.76%
Klotho Neurosciences Inc stock is traded at $0.231, with a volume of 13.20M.
It is up +2.85% in the last 24 hours and up +35.88% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.2246
Open:
$0.2149
24h Volume:
13.20M
Relative Volume:
1.30
Market Cap:
$6.47M
Revenue:
-
Net Income/Loss:
$-4.23M
P/E Ratio:
-1.0958
EPS:
-0.2108
Net Cash Flow:
-
1W Performance:
+32.45%
1M Performance:
+35.88%
6M Performance:
-33.62%
1Y Performance:
+0.00%
1-Day Range:
$0.20
$0.31
1-Week Range:
$0.1154
$0.5675
52-Week Range:
$0.1135
$0.9473
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
646-916-5315
Address
1115 BROADWAY, NEW YORK
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.231 | 4.97M | 0 | -4.23M | 0 | -0.2108 |
|
ONC
Beigene Ltd Adr
|
233.37 | 25.21B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.66 | 112.83B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2632 | 40.72M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.54 | 62.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.58 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Nasdaq Top 5 Premarket Losers: Healthcare Triangle, Klotho Neurosciences, New Fortress Energy, NanoVibronix, MDJM - MSN
3 Penny Stocks to Watch Now, 5/15/25 - TipRanks
Klotho Neurosciences, Inc. SEC 10-Q Report - TradingView
Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Boosting Klotho Protein Slows Aging and Enhances Health - Neuroscience News
Klotho: a protein that promotes healthy aging and improves longevity - EurekAlert!
Klotho Neurosciences Inc (KLTO) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Investing in Klotho Neurosciences Inc (KLTO) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - uspostnews.com
The association between Serum Klotho protein and Stroke ：a cross-sectional study from NHANES 2007-2016 - Frontiers
Form PRE 14AOther preliminary proxy statements - ADVFN
Klotho Neurosciences faces Nasdaq delisting risk By Investing.com - Investing.com South Africa
Klotho Neurosciences faces Nasdaq delisting risk - Investing.com
Finance Watch: No Big Post-ASCO Follow-On Frenzy, But Biotech Had A Good Week - insights.citeline.com
Klotho Neurosciences receives Nasdaq compliance extension By Investing.com - Investing.com India
Klotho Neurosciences receives Nasdaq compliance extension - Investing.com Australia
KLTO stock touches 52-week low at $0.19 amid sharp annual decline - Investing.com India
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Klotho Neurosciences to Acquire SkyBell Tech Subsidiary By Investing.com - Investing.com South Africa
Klotho Neurosciences to Acquire SkyBell Tech Subsidiary - Investing.com
Klotho Neurosciences, Inc. SEC 10-K Report - TradingView
Klotho Neurosciences Inc. (KLTO) reports earnings - qz.com
KLTO stock touches 52-week low at $0.25 amid sharp annual decline - Investing.com Canada
Exelixis (NASDAQ:EXEL) & Klotho Neurosciences (NASDAQ:KLTO) Financial Analysis - Defense World
Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews
Klotho Neurosciences faces Nasdaq delisting By Investing.com - Investing.com Australia
Klotho Neurosciences faces Nasdaq delisting - Investing.com India
Citigroup Begins Coverage on Candel Therapeutics (NASDAQ:CADL) - Defense World
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Critical Comparison: Klotho Neurosciences (NASDAQ:KLTO) versus IN8bio (NASDAQ:INAB) - Defense World
Klotho Neurosciences, Inc. announced that it expects to receive $2 million in funding -January 22, 2025 - Marketscreener.com
Klotho Neurosciences secures $2M in convertible notes and warrants By Investing.com - Investing.com Canada
Klotho Neurosciences secures $2M in convertible notes and warrants - Investing.com India
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco - The Manila Times
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Head to Head Contrast: Klotho Neurosciences (NASDAQ:KLTO) & ImmunityBio (NASDAQ:IBRX) - Defense World
Klotho Neurosciences, Inc. announced that it has received $1 million in funding from ACM Projektentwicklung GmbH - Marketscreener.com
Klotho Neurosciences secures $1.2 million convertible note By Investing.com - Investing.com Canada
Klotho Neurosciences secures $1.2 million convertible note - Investing.com India
Klotho Neurosciences, Inc. Appoints Dr. Merit Cudkowicz to Scientific Advisory Board - Marketscreener.com
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board - The Manila Times
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts - GlobeNewswire
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board - Yahoo Finance
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):